Meeting Banner
Abstract #1359

Hyperpolarized Helium-3 MRI Detects the Effects of a Cftr Potentiator (Ivacaftor) Therapy in Subjects with Cystic Fibrosis and the G551D Mutation

Talissa A. Altes1, Mac Johnson2, John P. Mugler1, Deborah Froh3, Lucia Flors1, Grady Wilson Miller1, Jaime H. Mata1, Carlos L. Salinas1, Nick Tustison1, Po-Shun Lee2, Tao Song2, Karl Yen2, Eduard E. de Lange1, Martyn C. Botfield2

1Radiology, University of Virginia, Charlottesville, VA, United States; 2Vertex Pharmaceuticals Incorporated, Cambridge, MA, United States; 3Pediatric Pulmonology, University of Virginia, Charlottesville, VA, United States

This study to evaluate the ability of hyperpolarized helium-3 MR ventilation imaging to detect the effects of treatment with ivacaftor, a CFTR potentiator, demonstrated a rapid onset of improvement in lung ventilation with treatment and equally rapid return to near baseline ventilation following cessation of treatment. Eight subjects with CF were imaged on 5 different days, 2 weeks apart (Days 0, 14, 28, 42, and 56), and were treated with Ivacaftor from Days 14 to 42. Interim data analysis has been conducted on the first 4 subjects in the study, although all 8 subjects have completed the trial.

Abstract PDF

Keywords

ability achieved acquisition acquisitions action adult alleles analyzed appearing approximately automated available background bacterial biomedical body breath cell cessation chronic class clearance coil common completed consisted control controlled cystic days decreased defect defective defects define designed detect detects dimensional disorders distributed divided dosing drug dysfunction encodes endpoint enough evaluate fibrosis fixed fluid focused free frequency functioning funded gating greater helium highest hold identified improvement incorporated indicating individual infection interim ions john larger lead least lethal linearly location longer lung lungs majority materials membrane molecular mucus mutation mutations near nick nitrogen nutritional occurred older onset pathology pediatric period pharmaceuticals placebo plastic polarizations polarized poorly possibly potential predicted prior protein proton quantify rapid receive recessive response return sampling screening sensitive shun song springs steady studies subject subjects substantially suggesting support system technologies term therapeutic therapy thickened transport treat treatment trial trials tuned underway underwent ventilated ventilation vertex volume wash washout weeks whole years